ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $659,148 | -4.6% | 31,629 | +9.6% | 0.10% | -7.2% |
| Q2 2023 | $691,101 | +16.1% | 28,856 | -8.7% | 0.11% | -33.9% |
| Q1 2023 | $595,013 | +116.1% | 31,616 | +82.8% | 0.17% | +257.4% |
| Q4 2022 | $275,289 | -44.2% | 17,292 | -42.6% | 0.05% | -48.9% |
| Q3 2022 | $493,000 | +150.3% | 30,118 | +115.3% | 0.09% | +100.0% |
| Q2 2022 | $197,000 | -65.3% | 13,987 | -40.3% | 0.05% | -70.5% |
| Q1 2022 | $568,000 | +159.4% | 23,448 | +149.7% | 0.16% | +164.4% |
| Q4 2021 | $219,000 | -42.7% | 9,389 | +31.3% | 0.06% | -56.9% |
| Q4 2020 | $382,000 | -40.7% | 7,153 | -54.2% | 0.14% | -49.4% |
| Q3 2020 | $644,000 | +199.5% | 15,616 | +251.3% | 0.27% | +153.3% |
| Q2 2020 | $215,000 | +1691.7% | 4,445 | +519.1% | 0.11% | +94.5% |
| Q4 2018 | $12,000 | – | 718 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |